Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Multiple Myeloma and Other Plasma Cell Neoplasms

  • Book
  • © 2018

Overview

Editors:
  1. Meletios A. Dimopoulos

    1. School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Thierry Facon

    1. Service des Maladies du Sang, CHRU Lille Hôpital Claude Huriez, Lille, France

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. Evangelos Terpos

    1. School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Discusses all aspects of novel and emerging therapies for myeloma and other plasma cell neoplasms
  • Includes new diagnostic criteria for multiple myeloma
  • Presents recently acquired data relating to prognosis and minimal residual disease

Part of the book series: Hematologic Malignancies (HEMATOLOGIC)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (12 chapters)

  1. Front Matter

    Pages i-vi
    Download chapter PDF

  2. Epidemiology and Pathophysiology of Multiple Myeloma

    • Malin Hultcrantz, Gareth J. Morgan, Ola Landgren
    Pages 1-15

  3. Diagnosis and Staging of Multiple Myeloma and Related Disorders

    • S. Vincent Rajkumar, Rafael Fonseca, Jesus F. San Miguel
    Pages 17-28

  4. Treatment of Transplant Eligible Patients with Multiple Myeloma

    • P. Sonneveld, H. Einsele, A. M. Brioli, M. Cavo
    Pages 29-60

  5. Treatment of Elderly Patients with Multiple Myeloma

    • Eileen Mary Boyle, Thierry Facon, Maria Victoria Mateos, Antonio Palumbo
    Pages 61-71

  6. Treatment of Relapsed/Refractory Patients with Multiple Myeloma

    • Jacob P. Laubach, Philippe Moreau, Meletios A. Dimopoulos, Paul G. Richardson
    Pages 73-96

  7. Minimal Residual Disease in Multiple Myeloma

    • Noemi Puig, Carmela Palladino, Bruno Paiva, Marco Ladetto
    Pages 97-109

  8. Bone Disease

    • Evangelos Terpos, Nikolaos Kanellias, Noopur Raje
    Pages 111-140

  9. Other Complications of Multiple Myeloma

    • Heinz Ludwig, Meletios-Athanasios Dimopoulos, Evangelos Terpos
    Pages 141-156

  10. Plasma Cell Leukemia and Extramedullary Plasmacytoma

    • Morie A. Gertz, Laura Rosinol, Joan Bladé
    Pages 157-175

  11. POEMS Syndrome

    • Dimitrios C. Ziogas, Angela Dispenzieri, Evangelos Terpos
    Pages 177-189

  12. Waldenström’s Macroglobulinemia

    • Steven P. Treon, Giampaolo Merlini, Meletios A. Dimopoulos
    Pages 191-220

  13. Primary Systemic Amyloidosis

    • Efstathios Kastritis, Ashutosh Wechalekar, Giampaolo Merlini
    Pages 221-245
Back to top

Keywords

About this book

This book is a comprehensive source of up-to-date information on plasma cell neoplasms. Key features include the provision of new criteria for the diagnosis of symptomatic multiple myeloma requiring treatment and the description of novel therapies for myeloma and other plasma cell neoplasms that have only very recently been licensed by the U.S. Food and Drug Administration. Examples include lenalidomide as first-line therapy, panobinostat in combination with bortezomib plus dexamethasone for relapsed/refractory myeloma, ibrutinib for Waldenström’s macroglobulinemia, and new therapeutic regimens for systemic amyloidosis and POEMS syndrome. Information is also provided on drug combinations that have shown encouraging results and are very near to approval. Other important aspects covered in the book are the role of different imaging modalities in workup and the significance of newly acquired data relating to prognosis and minimal residual disease. Readers will find Multiple Myelomaand Other Plasma Cell Neoplasms to be a rich source of knowledge that will be invaluable in improving patient management. 

Editors and Affiliations

  • School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

    Meletios A. Dimopoulos, Evangelos Terpos

  • Service des Maladies du Sang, CHRU Lille Hôpital Claude Huriez, Lille, France

    Thierry Facon

About the editors


Bibliographic Information

  • Book Title: Multiple Myeloma and Other Plasma Cell Neoplasms

  • Editors: Meletios A. Dimopoulos, Thierry Facon, Evangelos Terpos

  • Series Title: Hematologic Malignancies

  • DOI: https://doi.org/10.1007/978-3-319-25586-6

  • Publisher: Springer Cham

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer International Publishing Switzerland 2018

  • Hardcover ISBN: 978-3-319-25584-2Published: 12 March 2018

  • Softcover ISBN: 978-3-030-13242-2Published: 21 November 2019

  • eBook ISBN: 978-3-319-25586-6Published: 16 February 2018

  • Series ISSN: 2197-9766

  • Series E-ISSN: 2197-9774

  • Edition Number: 1

  • Number of Pages: VI, 245

  • Number of Illustrations: 14 illustrations in colour

  • Topics: Hematology, Oncology, Immunology

Publish with us

Policies and ethics

Back to top

Search

Navigation